
Digital Therapeutics and Their Impact on Future Diabetes Treatment
This American Diabetes Alert Day, learn how digital therapeutics can improve diabetes awareness, prevention, access to screenings, and better…
This American Diabetes Alert Day, learn how digital therapeutics can improve diabetes awareness, prevention, access to screenings, and better…
More than three million Americans are living with bleeding disorders. These disorders—including hemophilia, von Willebrand disease, and other rare…
Cancer is a leading cause of death worldwide. Despite the lack of a definitive cure for cancer, there are many types of cancer treatments. A…
Sickle Cell Disease (SCD) is a disease with few curative treatments that affects people globally. Both young and older patients who struggle with SCD…
To mark World Blood Donor Day, we interviewed two members of our PRA family who have gone above and beyond for Red Cross efforts. We discussed why…
The American Society of Hematology (ASH) 2019 meeting, the world’s biggest hematology conference, addressed a number of new and exciting…
As the oncology environment continues to grow towards more targeted therapies, it is imperative that patient recruitment strategies focus on how to…
This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia…
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…
As a recognized leader in conducting complex, global oncology/hematology trials, PRA has contributed to the approval of 16 important drugs. During…